FDB-24528-14639
1 vaccination
1 coded response
3 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 370 / TN
- Registered
- 2021-03-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-03-17
Dose 1 — Moderna
-
2021-03-26
Registered in v-safe
- 2021-03-26
-
2021-09-15
Survey response — 6 months, dose 1MedDRA: Menstruation irregular, Uterine dilation and curettage — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Irregular periods, very strong. Had to have a D&C. · Healthcare visit (other): D&C procedureMedDRA releases: 2024-11 · check-in free text available
-
2021-09-15
Report sent to call center — 6 months, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2021-09-17
- 2022-03-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-17 | Moderna |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-09-15 | Unsuccessful |
Free text
Release 9 — 6 months, dose 1
Symptoms: Irregular periods, very strong. Had to have a D&C.
Healthcare visit (other): D&C procedure
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Uterine dilation and curettage | · | · | ✓ |
| SD | Menstruation irregular | · | · | ✓ |
| SD | Uterine dilation and curettage | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release